Biosion, Inc.
Clinical trials sponsored by Biosion, Inc., explained in plain language.
-
New shot shows promise for tough eczema cases
Symptom relief CompletedThis study tested an experimental drug called BSI-045B in 22 adults with moderate to severe atopic dermatitis (eczema). Participants received injections weekly for 4 weeks, then every 2 weeks up to 24 weeks. The main goals were to see if the drug safely reduces eczema severity by…
Phase: PHASE2 • Sponsor: Biosion, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New antibody shot shows promise for eczema in early trial
Symptom relief CompletedThis early-stage trial tested an experimental antibody injection called BSI-045B in 54 healthy volunteers and people with atopic dermatitis (eczema). The main goal was to check safety and tolerability, with some early looks at how well it might control symptoms. The study is comp…
Phase: PHASE1 • Sponsor: Biosion, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 18:51 UTC